Skip to content

Clinical trials

Completed Neoplasm Metastasis trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Status: Completed Country / region: Australia Clear all

98 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20023
20032
20042
20052
20063
20077
20085
20096
20107
20115
20126
20135
20146
20153
20166
20177
20182
20191
20204
20214
20221
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed98

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi9
Pfizer8
Novartis Pharmaceuticals5
Amgen4
Eli Lilly and Company4
OncoMed Pharmaceuticals, Inc.4
AbbVie3
AstraZeneca3
Bristol-Myers Squibb3
EMD Serono Research & Development Institute, Inc.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis98
Neoplasms26
Breast Neoplasms21
Colorectal Neoplasms14
Carcinoma, Non-Small-Cell Lung11
Melanoma10
Pancreatic Neoplasms8
Lung Neoplasms7
Brain Neoplasms6
Carcinoma, Renal Cell6

Trials

Showing 1 to 25 of 98. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.